Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis

Corrigendum: Biomarkers of response to ocrelizumab in relapsing–remitting multiple sclerosis

Saved in:
Bibliographic Details
Main Authors: Fernando Rodríguez-Jorge, José Ignacio Fernández-Velasco, Noelia Villarrubia, Julia Gracia-Gil, Eva Fernández, Virginia Meca-Lallana, Carolina Díaz-Pérez, Susana Sainz de la Maza, Eva María Pacheco, Ana Quiroga, Lluis Ramió-Torrentà, Sergio Martínez-Yélamos, Laura Bau, Enric Monreal, Ana López-Real, Alexander Rodero-Romero, Laura Borrega, Santiago Díaz, Pablo Eguía, Mercedes Espiño, Juan Luis Chico-García, Francisco Javier Barrero, María Luisa Martínez-Ginés, José Manuel García-Domínguez, Soraya De la Fuente, Irene Moreno, Raquel Sainz-Amo, M. Alba Mañé-Martínez, Ana Caminero, Fernando Castellanos-Pinedo, Ana Gómez López, Andrés Labiano-Fontcuberta, Lucía Ayuso, Rossana Abreu, Miguel Ángel Hernández, José Meca-Lallana, Lorena Martín-Aguilar, Alfonso Muriel García, Jaime Masjuan, Lucienne Costa-Frossard, Luisa María Villar
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-12-01
Series:Frontiers in Immunology
Subjects:
multiple sclerosis
ocrelizumab
neurofilament light chain
glial fibrillary acidic protein
serum biomarkers
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1535051/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items